Search Keyword:


Search option:


IID00802
UniprotP41279
ProteinMitogen-activated protein kinase kinase kinase 8
GeneMAP3K8
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
467
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 66-395 Monomer :
 Evidence X-RAY 5iu2 A Reference
       Region 5iu2 A 66-72 disorder
       Region 5iu2 A 73-93 order
       Region 5iu2 A 94-97 disorder
       Region 5iu2 A 98-138 order
       Region 5iu2 A 139-139 disorder
       Region 5iu2 A 140-389 order
       Region 5iu2 A 390-395 disorder
 Evidence X-RAY 5iu2 B Reference
       Region 5iu2 B 66-72 disorder
       Region 5iu2 B 73-93 order
       Region 5iu2 B 94-96 disorder
       Region 5iu2 B 97-138 order
       Region 5iu2 B 139-139 disorder
       Region 5iu2 B 140-389 order
       Region 5iu2 B 390-395 disorder
 Evidence X-RAY 4y83 A Reference
       Region 4y83 A 66-72 disorder
       Region 4y83 A 73-90 order
       Region 4y83 A 91-101 disorder
       Region 4y83 A 102-331 order
       Region 4y83 A 332-338 disorder
       Region 4y83 A 339-389 order
       Region 4y83 A 390-395 disorder
 Evidence X-RAY 4y83 B Reference
       Region 4y83 B 66-72 disorder
       Region 4y83 B 73-92 order
       Region 4y83 B 93-102 disorder
       Region 4y83 B 103-146 order
       Region 4y83 B 147-148 disorder
       Region 4y83 B 149-332 order
       Region 4y83 B 333-336 disorder
       Region 4y83 B 337-390 order
       Region 4y83 B 391-395 disorder
 Evidence X-RAY 4y83 C Reference
       Region 4y83 C 66-73 disorder
       Region 4y83 C 74-90 order
       Region 4y83 C 91-102 disorder
       Region 4y83 C 103-127 order
       Region 4y83 C 128-128 disorder
       Region 4y83 C 129-146 order
       Region 4y83 C 147-149 disorder
       Region 4y83 C 150-277 order
       Region 4y83 C 278-278 disorder
       Region 4y83 C 279-332 order
       Region 4y83 C 333-335 disorder
       Region 4y83 C 336-353 order
       Region 4y83 C 354-356 disorder
       Region 4y83 C 357-389 order
       Region 4y83 C 390-395 disorder
 Evidence X-RAY 4y85 A Reference
       Region 4y85 A 66-72 disorder
       Region 4y85 A 73-94 order
       Region 4y85 A 95-102 disorder
       Region 4y85 A 103-139 order
       Region 4y85 A 140-142 disorder
       Region 4y85 A 143-390 order
       Region 4y85 A 391-395 disorder
 Evidence X-RAY 4y85 B Reference
       Region 4y85 B 66-72 disorder
       Region 4y85 B 73-93 order
       Region 4y85 B 94-102 disorder
       Region 4y85 B 103-139 order
       Region 4y85 B 140-142 disorder
       Region 4y85 B 143-390 order
       Region 4y85 B 391-395 disorder
 Evidence X-RAY 4y85 C Reference
       Region 4y85 C 66-72 disorder
       Region 4y85 C 73-92 order
       Region 4y85 C 93-102 disorder
       Region 4y85 C 103-137 order
       Region 4y85 C 138-142 disorder
       Region 4y85 C 143-390 order
       Region 4y85 C 391-395 disorder
Seqphosphorylation
    141-141 Phosphoserine
    80-80 Phosphothreonine
    290-290 Phosphothreonine
    400-400 Phosphoserine
    443-443 Phosphoserine
 
Prediction
NeProc
Disorder 1-7,40-79,84-89,97-110,410-440,445-449,458-467
Order 8-39,80-83,90-96,111-409,441-444,450-457
ProS 1-7,40-44,58-79,84-89,100-110,410-440,445-449,458-467
AlphaFold
Disorder 1-73,96-103,133-150,392-467
Order 74-95,104-132,151-391
Pfam Hmmer
PF00069 136-388 5.1e-50
SEG 405-419
Function
Function in SwissProt
Required for lipopolysaccharide (LPS)-induced, TLR4-mediated activation of the MAPK/ERK pathway in macrophages, thus being critical for production of the proinflammatory cytokine TNF-alpha (TNF) during immune responses. Involved in the regulation of T-helper cell differentiation and IFNG expression in T-cells. Involved in mediating host resistance to bacterial infection through negative regulation of type I interferon (IFN) production. In vitro, activates MAPK/ERK pathway in response to IL1 in an IRAK1-independent manner, leading to up-regulation of IL8 and CCL4. Transduces CD40 and TNFRSF1A signals that activate ERK in B-cells and macrophages, and thus may play a role in the regulation of immunoglobulin production. May also play a role in the transduction of TNF signals that activate JNK and NF-kappa-B in some cell types. In adipocytes, activates MAPK/ERK pathway in an IKBKB-dependent manner in response to IL1B and TNF, but not insulin, leading to induction of lipolysis. Plays a role in the cell cycle. Isoform 1 shows some transforming activity, although it is much weaker than that of the activated oncogenic variant.